Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perennial Malaria Chemoprevention (PMC) Effect Study: Nigeria Operational Feasibility and Effectiveness

NCT06155448 is registered in ClinicalTrials.gov with Malaria Consortium as lead sponsor.

NCT NCT06155448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06155448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perennial Malaria Chemoprevention (PMC) Effect Study: Nigeria Operational Feasibility and Effectiveness
Lead sponsor
Malaria Consortium
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 8, 2023
Completion date
December 31, 2026
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria